AI & Robotics Watch: Perceptive and Yomi

All three vendors have FDA-cleared assistive products, but their submitted performance studies used different findings, datasets, and endpoints. The numbers cannot be treated as a head-to-head ranking.

Open the full comparison and office pilot protocol

Clinical accuracy, treatment pressure, payer relationships, data governance, and the ability to document disagreements all matter before an office adopts an AI overlay.

Perceptive positions itself as an AI-first dental diagnostics and workflow company, describing an intraoral-scanner + OCT + AI stack and a long-term automation roadmap.

Open the dedicated Perceptive page

• Higher-quality visualization and earlier lesion detection support.
• More standardized case communication and documentation.
• Possibly faster data capture and triage if workflow integration is strong.

• Clinical claims must be separated from prototype or marketing demonstrations.
• Performance can vary by lesion type, scanner protocol, and operator workflow.
• Downstream payer/audit behavior can change once AI-assisted findings become routine.

Yomi is positioned by Neocis as an FDA-cleared robotic dental surgery platform used for implant placement with dynamic guidance and haptic constraints.

Neocis reports a growing clinical footprint and publication base, and peer-reviewed pilot data suggests tighter angular/horizontal deviation versus freehand placement in studied settings.

• Pilot and company-linked studies are informative but not definitive for all practices.
• Skill transfer, setup burden, and team training can dominate real-world ROI.
• Case mix and planning discipline often matter as much as hardware category.

Mal-ID frames its work around AI support for visually detectable oral-cancer lesions. It belongs on the watchlist because the clinical problem is real, but the evidence, regulatory, and workflow questions still matter.

Open the Mal-ID page

Oral-cancer AI should be evaluated as decision support and triage infrastructure, not as a shortcut around clinical exam, referral judgment, or biopsy pathways.